Carvotroline
Carvotroline is a chemical compound that has been studied for its potential use in the treatment of various neurological and psychiatric disorders. It is classified as a selective serotonin receptor modulator, specifically targeting the 5-HT1A receptor.
Pharmacology[edit | edit source]
Carvotroline acts as a partial agonist at the 5-HT1A receptor, which is a subtype of the serotonin receptor. This receptor is involved in the regulation of mood, anxiety, and cognition. By modulating the activity of this receptor, carvotroline may influence the release of neurotransmitters such as serotonin and dopamine, which are critical in mood regulation and cognitive processes.
Mechanism of Action[edit | edit source]
The mechanism of action of carvotroline involves its interaction with the 5-HT1A receptor. As a partial agonist, it binds to the receptor and activates it, but not to the full extent as the natural ligand, serotonin. This partial activation can lead to a balance in receptor activity, potentially reducing symptoms of anxiety and depression without the full side effects associated with complete agonists or antagonists.
Clinical Research[edit | edit source]
Research on carvotroline has primarily been conducted in preclinical and early clinical trials. Studies have shown that it may have anxiolytic and antidepressant effects, making it a candidate for further investigation in the treatment of anxiety disorders and depression. However, more extensive clinical trials are necessary to fully understand its efficacy and safety profile.
Potential Applications[edit | edit source]
Carvotroline's modulation of the 5-HT1A receptor suggests potential applications in treating conditions such as:
Side Effects[edit | edit source]
As with many drugs affecting the central nervous system, carvotroline may have side effects. These could include dizziness, nausea, headache, and fatigue. The exact side effect profile will need to be established through clinical trials.
Also see[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
